Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Biochemical Markers, Genotype, and Inflammation in Pediatric Inflammatory Bowel Disease: A Danish Population-Based Study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Molecular Pathogenesis and Current Therapy in Intrahepatic Cholangiocarcinoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Biological treatment of Crohn's disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Long-term, clinical follow-up in fatty liver patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Insulin-like growth factor 1 and growth hormone in chronic liver disease.

    Publikation: Bidrag til tidsskriftReviewForskning

  5. Sex, sex hormones and chronic liver diseases

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Plasma calprotectin is superior to serum calprotectin as a biomarker of intestinal inflammation in ulcerative colitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Editorial: suicide and IBD-a call to action. Authors' reply

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Pragmatic Home-Based Exercise after Total Hip Arthroplasty - Silkeborg: Protocol for a prospective cohort study (PHETHAS-1)

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Our aim was to characterize the biochemical markers at diagnosis in patients with inflammatory bowel disease (IBD), to assess the utility of these to predict disease course and investigate if genotype influences biochemical markers of inflammation. Summary: Patients were included from a population-based pediatric IBD cohort from Eastern Denmark. Data on biochemical markers and medical as well as surgical treatment were registered at diagnosis, 30 days, 6 and 12 months after diagnosis. Fifty-two single nucleotide polymorphisms (SNPs) known to be associated with IBD were selected for genotyping based on previous genetic studies. Key messages: A total of 190 IBD patients (97 ulcerative colitis [UC], 87 Crohn's disease [CD], and 6 IBD unclassified) were included. UC patients with extensive disease had higher C-reactive protein, erythrocyte sedimentation rate, and platelet count at diagnosis compared to UC patients with less extensive disease. No similar differences between disease extent groups were found in CD. Low albumin at diagnosis was associated with an increased risk of surgery in both UC (OR 1.35; 95% CI: 1.05-1.75) and CD patients (OR 1.23; 95% CI: 1.01-1.48) and increased use of azathioprine and anti-tumor necrosis factor alpha use in the total IBD cohort (OR 1.15; 95% CI: 1.04-1.27 and OR 1.19 [1.08-1.34]). One SNP (rs4986791 in the TLR-4 locus) and 2 SNPs (rs6785049 in the Pregnane-x-receptor gene and rs10500264 in the SLCA10 gene) were associated with a change in albumin and hemoglobin over time respectively in our IBD cohort. Our study confirms albumin to be a marker of severe disease course. Furthermore, the patient's genotype possibly affects the inflammatory response. Future studies in larger pediatric cohorts are needed to confirm our findings.

OriginalsprogEngelsk
TidsskriftDigestive Diseases
Vol/bind37
Udgave nummer2
Sider (fra-til)140-146
Antal sider7
ISSN0257-2753
DOI
StatusUdgivet - jan. 2019

ID: 55618008